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Background
Cardiac allograft vasculopathy (CAV) continues to limit
the long-term survival of heart transplant recipients.
CAV affects both the epicardial arteries and the micro-
vessels, however it does so independently, and epicardial
and microvascular disease are both independently pre-
dictive of prognosis. Despite being associated with con-
siderable limitations, coronary angiography has a class I
recommendation for CAV surveillance and annual or
biannual surveillance angiography is performed routinely
in most centers. The aim of this study was to evaluate the
diagnostic performance of multiparametric CMR in CAV,
and to compare the performance of CMR to that of inva-
sive coronary angiography, using contemporary invasive
epicardial artery and microvascular assessment techniques
as reference standards.
Methods
All transplant recipients referred for surveillance angiogra-
phy at a single UK transplant center over a 2-year period
were prospectively screened for study eligibility. Patients
prospectively underwent coronary angiography followed
by coronary intravascular ultrasound (IVUS; epicardial
artery reference standard) and index of microcirculatory
resistance (IMR; microvascular reference standard).
Within one month patients underwent multiparametric
CMR. CMR assessment included LV volumetrics, circum-
ferential strain and strain rate, torsion (circumferential-
longitudinal shear), pixel-wise absolute myocardial blood
flow quantification using generalized Tikhonov deconvolu-
tion with a b-spline representation of the impulse response
function, late gadolinium enhancement and T1 mapping/
extracellular volume measurement. Angiographic and
CMR data were compared with the invasive epicardial artery
(IVUS intima-media ("plaque”) volume index) and micro-
vascular (IMR) reference standards. In addition, 10 age-
and sex-matched healthy volunteers underwent CMR.
Results
Forty-eight patients were recruited; median 7.1 years
(IQR 4.6-10.3) since transplantation. Mean IVUS plaque
volume index was 22.4 ± 9.8%; mean IMR was 23.7 ± 12.5.
Selected univariable and multivariable associations between
patient, angiographic and CMR data and IVUS plaque
volume index and IMR are summarized in Table 1. CMR
myocardial perfusion reserve was the only independent
predictor of both epicardial (b = -0.57, p < 0.001) and
microvascular disease (b = -0.60, p < 0.001) on stepwise
multivariable regression. Myocardial perfusion reserve out-
performed angiography for detecting moderate CAV (AUC
0.89, 95% confidence intervals 0.79-1.0 v 0.59 (0.42-0.77)
respectively, p = 0.01; Figure 1A) and severe CAV (AUC
0.88 (0.78-0.98) v 0.67 (0.52-0.82), p = 0.05; Figure 1B).
Conclusions
CAV, including epicardial and microvascular components,
can be detected more accurately using non-invasive CMR-
based absolute myocardial blood flow assessment than
with invasive coronary angiography, the current clinical
surveillance technique.
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Table 1 Associations between patient characteristics, angiography data and CMR data with invasive reference
standards of epicardial artery disease (IVUS plaque volumes index; 1) and microvascular disease (IMR; 2).
1. Associations with coronary intravascular ultrasound (IVUS) plaque volume index
Univariable associations A. Patient characteristics b p value
Time since transplantation 0.49 0.001
Donor age 0.29 0.058
B. Angiography data
Maximum angiographic stenosis 0.33 0.024
C. CMR data
Early diastolic SR -0.38 0.014
MPR -0.55 < 0.001
Infarct LGE 0.35 0.022
Multivariable stepwise regression A. Including patient characteristics and angiographic data
Time since transplantation 0.49 0.001
B. Including patient characteristics and CMR data
Time since transplantation 0.47 < 0.001
Early diastolic SR -0.24 0.049
MPR -0.57 < 0.001
2. Associations with index of microcirculatory resistance (IMR)
Univariable associations A. Patient characteristics
Donor age 0.39 0.007
Donor hypertension 0.35 0.016
B. Angiography data




MPR -0.55 < 0.001
Multivariable stepwise regression Donor hypertension 0.29 0.012
EF -0.26 0.024
MPR -0.60 < 0.001
Only selected data is shown due to table size constraints. 1. On univariable analysis, maximum angiographic stenosis showed a significant association with
plaque volume index, however after correcting for time since transplantation, this relationship was no longer significant. Early diastolic strain rate (SR), myocardial
perfusion reserve (MPR) and infarct late gadolinium enhancement (LGE) were significantly associated with plaque volume index on univariable analyses, but only
MPR and early diastolic SR remained independently associated with plaque volume index on multivariable analysis. 2. Maximum angiographic stenosis was not
significantly associated with IMR on univariable analysis. Patient characteristics including donor age and donor hypertension showed significant associations with
IMR on univariable analyses, as did CMR parameters such as LV ejection fraction (EF), peak systolic circumferential strain (εcc) and MPR. On multivariable analysis
only donor hypertension, EF and MPR remained independently associated with IMR.
Figure 1 Diagnostic performance of cardiovascular magnetic resonance myocardial perfusion reserve and angiography for detecting
cardiac allograft vasculopathy (CAV). Diagnostic performance of cardiovascular magnetic resonance myocardial perfusion reserve (CMR) and
angiography (angio) for detecting; (A) moderate cardiac allograft vasculopathy, defined as > median epicardial or microvascular disease; and (B)
severe cardiac allograft vasculopathy, defined as > 75th centile epicardial or microvascular disease.
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